The American Journal of Surgery
Volume 194, Issue 2 , Pages 255-262 , August 2007

Pyrrolidine dithiocarbamate prevents 60 minutes of warm mesenteric ischemia/reperfusion injury in rats

  • Zafer Teke, M.D.

      Affiliations

    • Faculty of Medicine, Department of General Surgery, Pamukkale University, 20070 Denizli, Turkey
    • Corresponding Author InformationCorresponding author. Pamukkale University, School of Medicine, Department of General Surgery, 20070 Kinikli, Denizli, Turkey. Tel.: +90 542 2644046; fax: +90 258 2134922.
    • ,
  • Burhan Kabay, M.D.

      Affiliations

    • Faculty of Medicine, Department of General Surgery, Pamukkale University, 20070 Denizli, Turkey
    • ,
  • Faruk Onder Aytekin, M.D.

      Affiliations

    • Faculty of Medicine, Department of General Surgery, Pamukkale University, 20070 Denizli, Turkey
    • ,
  • Cigdem Yenisey, Ph.D.

      Affiliations

    • Faculty of Medicine, Department of Biochemistry, Adnan Menderes University, 09100 Aydin, Turkey
    • ,
  • Nese Calli Demirkan, M.D.

      Affiliations

    • Faculty of Medicine, Department of Pathology, Pamukkale University, 20070 Denizli, Turkey
    • ,
  • Mustafa Sacar, M.D.

      Affiliations

    • Faculty of Medicine, Department of Cardiovascular Surgery, Pamukkale University, 20070 Denizli, Turkey
    • ,
  • Ergun Erdem, M.D.

      Affiliations

    • Faculty of Medicine, Department of General Surgery, Pamukkale University, 20070 Denizli, Turkey
    • ,
  • Akin Ozden, M.D.

      Affiliations

    • Faculty of Medicine, Department of General Surgery, Pamukkale University, 20070 Denizli, Turkey

Received 20 March 2006 ,Revised 16 June 2006

References 

  1. Tisi P, Shearman CP. Systemic consequences of reperfusion injury. In:  Grace PA,  Mathie RT editor. Ischaemia-Reperfusion Injury. London: Blackwell Science; 1999;p. 20–30
  2. Haglund U, Bulkley GB, Granger DN. On the pathophysiology of intestinal ischemic injury (Clinical review). Acta Chir Scand. 1987;153:321–324
  3. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg. 1992;216:117–134
  4. Neary P, Redmond HP. Ischaemia-reperfusion injury and the systemic inflammatory response syndrome. In:  Grace PA,  Mathie RT editor. Ischemia-Reperfusion Injury. London: Blackwell Science; 1999;p. 123–136
  5. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol. 1986;251:567–574
  6. Hisama N, Yamaguchi Y, Okajima K, et al. Anticoagulant pretreatment attenuates the production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion of rat liver. Dig Dis Sci. 1996;41:1481–1486
  7. Li X-K, Suzuki H, Kimura T, et al. Ulinastatin, a protease inhibitor, attenuates intestinal ischemia/reperfusion injury. Transplant Proc. 1994;26:2423–2425
  8. Otamiri T. Oxygen radicals, lipid peroxidation, and neutrophil infiltration after small-intestinal ischemia and reperfusion. Surgery. 1989;105:593–597
  9. Yamaguchi Y, Akizuki E, Ichiguchi O, et al. Neutrophil elastase inhibitor reduces neutrophil chemoattractant production after ischemia-reperfusion in rat liver. Gastroenterology. 1997;112:551–560
  10. Zimmermann BJ, Granger DN. Reperfusion injury. Surg Clin North Am. 1992;72:65–83
  11. Cicalese L, Caraceni P, Nalesnik MA, et al. Oxygen free radical content and neutrophil infiltration are important determinants in mucosal injury after rat small bowel transplantation. Transplantation. 1996;62:161–166
  12. Deshmukh DR, Mirochnitchenko O, Ghole VS, et al. Intestinal ischemiaand reperfusion injury in transgenic mice overexpressing copper-zinc superoxide dismutase. Am J Physiol. 1997;273:1130–1135
  13. Parks DA, Bulkley GB, Granger DN, et al. Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology. 1982;82:9–15
  14. Dosluoglu HH, Aktan AO, Yegen C, et al. The cytoprotective effects of verapamil and iloprost (ZK 36374) on ischemia/reperfusion injury of kidneys. Transplant Int. 1993;6:138–142
  15. Yegen C, Aktan AO, Buyukgebiz O, et al. Effect of verapamil and iloprost (ZK 36374) on endothelin release after mesenteric ischemia-reperfusion injury. Eur Surg Res. 1994;26:69–75
  16. Younes M, Mohr A, Schoenberg MH, et al. Inhibition of lipid peroxidation by superoxide dismutase following regional intestinal ischemiaand reperfusion. Res Exp Med. 1987;187:9–17
  17. Orrenius S, Nobel CS, Dobbelsteen DJ, et al. Dithiocarbamates and the redox regulation of cell death. Biochem Soc Trans. 1996;24:1032–1038
  18. Li C, Browder W, Kao RL. Early activation of transcription factor NF-κB during ischemia in perfused rat heart. Am J Physiol. 1999;276:543–552
  19. Ross SD, Kron IL, Gangemi JJ, et al. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB. Am J Physiol Lung Cell Mol Physiol. 2000;297:528–536
  20. Iseki A, Kambe F, Okumura K, et al. Pyrrolidine dithiocarbamate inhibits TNF-α-dependent activation of NF-κB by increasing intracellular copper level in human aortic smooth muscle cells. Biochem Biophys Res Commun. 2000;276:88–92
  21. Muller DN, Dechend R, Mervaala EMA, et al. NF-κB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension. 2000;35:193–201
  22. Liu SF, Ye X, Malik AB. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation. 1999;100:1330–1337
  23. Schreck R, Meire B, Mannel DN, et al. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med. 1992;175:1181–1194
  24. Borrello S, Demple B. NF kappa B-independent transcriptional induction of the human manganese superoxide dismutase gene. Arch Biochem Biophys. 1997;348:289–294
  25. Hartsfield CL, Alam J, Choi AMK. Transcriptional regulation of the heme oxygenase 1 gene by pyrrolidine dithiocarbamate. FASEB J. 1998;12:1675–1682
  26. Willis D, Moore AR, Frederick R, et al. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med. 1996;2:87–90
  27. Balla G, Jacob HS, Balla J, et al. Ferritin: a cytoprotective antioxidant stratagem of endothelium. J Biol Chem. 1992;67:18128–18153
  28. Yang L, Quan S, Abraham NG. Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am J Physiol. 1999;277:127–133
  29. Otterbein L, Sylvester SL, Choi AM. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol. 1995;13:595–601
  30. Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesions in low-flow states (A morphological, hemodynamic, and metabolic reappraisal). Arch Surg. 1970;101:478–483
  31. Suzuki K, Ota H, Sasagawa S, et al. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem. 1983;132:345–352
  32. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358
  33. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70–77
  34. Mallick IH, Yang W, Winslet MC, et al. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci. 2004;49:1359–1377
  35. Tetik C, Ozden A, Calli N, et al. Cytoprotective effect of trimetazidine on 60 minutes of intestinal ischemia-reperfusion injury in rats. Transplant Int. 1999;12:108–112
  36. Ozden A, Tetik C, Bilgihan A, et al. Antithrombin III prevents 60 min warm intestinal ischemia reperfusion injury in rats. Res Exp Med (Berl). 1999;198:237–246
  37. Lai HS, Chen WJ, Chiang LY. Free radical scavenging activity of fullerenol on the ischemia-reperfusion intestine in dogs. World J Surg. 2000;24:450–454
  38. Kalia N, Brown NJ, Hopkinson K, et al. FK409 inhibits both local and remote organ damage after intestinal ischaemia. J Pathol. 2002;197:595–602
  39. Thiemermann C. Membrane-permeable radical scavengers (tempol) for shock, ischemia-reperfusion injury, and inflammation. Crit Care Med. 2003;31:76–84
  40. Mallick IH, Yang WX, Winslet MC, et al. Pyrrolidine dithiocarbamate reduces ischemia-reperfusion injury of the small intestine. World J Gastroenterol. 2005;11:7308–7313
  41. Chatterjee PK, di Villa Bianca RD, Sivarajah A, et al. Pyrrolidine dithiocarbamate reduces renal dysfunction and injury caused by ischemia/reperfusion of the rat kidney. Eur J Pharmacol. 2003;482:271–280
  42. El Eter E, Hagar HH, Al-Tuwaijiri A, et al. Nuclear factor-kappa B inhibition by pyrrolidinedithiocarbamate attenuates gastric ischemia-reperfusion injury in rats. Can J Physiol Pharmacol. 2005;83:483–492
  43. Chen J, Wang G. Role of nuclear factor kappa B in intestine injury induced by hepatic ischemia reperfusion. J Huazhong Univ Sci Technolog Med Sci. 2004;24:284–291
  44. Savas C, Aras T, Cakmak M, et al. Pentoxifylline inhibits overflow and reduces intestinal reperfusion injury. J Pediatr Surg. 1997;32:905–910
  45. Nemeth ZH, Deitch EA, Szabo C, et al. Pyrrolidine dithiocarbamate inhibits NF-κB activation and IL-8 production in intestinal epithelial cells. Immunol Lett. 2003;85:41–46
  46. Satriano J, Schlondorff D. Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumor necrosis factor-α, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate (Evidence for involvement of reactive oxygen species). J Clin Invest. 1994;94:1629–1636
  47. Schmidt KN, Traeckner EB, Meier B, et al. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-κB. J Biol Chem. 1995;270:136–142
  48. Liu SF, Ye X, Malik AB. In vivo inhibition of nuclear factor-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol. 1997;159:3976–3983
  49. Jefferies H, Coster J, Khalil A, et al. Glutathione. Aust NZ J Surg. 2003;73:517–522
  50. Nakamura S, Sugiyama S, Fujioka D, et al. Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function. Circulation. 2003;108:1425–1427
  51. Koksoy C, Kuzu MA, Kuzu I, et al. Role of tumour necrosis factor in lung injury caused by intestinal ischaemia-reperfusion. Br J Surg. 2001;88:464–468
  52. Iglesias JL, LaNoue JL, Rogers TE, et al. Physiologic basis of pulmonary edema during intestinal reperfusion. J Surg Res. 1998;80:156–163
  53. Schmelling DJ, Caty MG, Oldham KT, et al. Evidence for neutrophil-related acute lung injury after intestinal ischemia-reperfusion. Surgery. 1989;106:195–201
  54. Dowdall JF, Winter DC, Bouchier-Hayes DJ. Inosine modulates gut barrier dysfunction and end organ damage in a model of ischemia-reperfusion injury. J Surg Res. 2002;108:61–68
  55. Koike K, Yamamoto Y, Hori Y, et al. Group II phospholipase A2 mediates lung injury in intestinal ischemia-reperfusion. Ann Surg. 2000;232:90–97
  56. Vural K, Liao H, Oz M, et al. Effects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model. Ann Thorac Surg. 2000;69:228–232
  57. Tavaf-Motamen H, Miner TJ, Starnes BW, et al. Nitric oxide mediates acute lung injury by modulation of inflammation. J Surg Res. 1998;78:137–142
  58. Ross SD, Kron IL, Gangemi JJ, et al. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB. Am J Physiol Lung Cell Mol Physiol. 2000;279:528–536

PII: S0002-9610(07)00336-4

doi: 10.1016/j.amjsurg.2006.06.054

The American Journal of Surgery
Volume 194, Issue 2 , Pages 255-262 , August 2007

Article Tools

* Image Usage & Resolution